Capricor Therapeutics, Inc. (CAPR) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
04M8M11M15M19M22M26M30MQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Operating Expenses

Research And Development ExpensesGeneral And Administrative ExpensesOther Expenses
05B10B15B20B25B30B35B40BQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025

EBITDA

EBITDA
-30B-26B-22B-19B-15B-11B-7B-4B1Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025

EPS

Revenue Variation (%)

Revenue Variation
-200-112-2562150238325412500Q3 2024Q4 2024Q1 2025

Income Variation (%)

Gross Profit VariationOperating Income Variation
025K50K75K100K125K150K175K200KQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Revenue YoY Variation (%)

Revenue YoY Variation
-200-175-150-125-100-74-49-241Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY Variation
038K75K112K150K188K225K262K300KQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Price-to-Earning Ratio

P/E Ratio
-20-17-15-12-10-7-4-21Q3 2024Q4 2024Q1 2025Q2 2025

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
0250M500M750M1B1B2B2B2BQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
000001111Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Expense Ratios

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
012345678Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
💰 Cash Flow Statement

Operating Cash Flow

Free Cash Flow

Cash At End Of Period
010M20M30M40M50M60M70M80MQ3 2024Q4 2024Q1 2025Q2 2025

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
012M25M38M50M62M75M88M100MQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025
🏦 Balance Sheet
📈 Key Metrics